Join our daily newsletter At The Bell to receive exclusive market insights
- The Calmer Co International (ASX:CCO) posts its quarterly report for the three-month period ending September 30, 2023
- The company achieved revenues of $597,000 for the quarter, marking a 96 per cent increase compared to the PCP
- CCO introduced Fiji Kava Noble Focus, its first Nootropic product, in the Australian market in July
- The company established a global distribution partnership with Leilo and entered into a distribution partnership with Naturally Elevated in Australia
- CCO last traded at 0.4 cents
The Calmer Co International (ASX:CCO) has released its quarterly report for the three-month period ending September 30, 2023.
The company reported continued strong sales performance, achieving revenues of $597,000 for the quarter, marking a 96 per cent increase compared to the prior corresponding period (PCP).
E-commerce sales grew to a record $359,000, representing a 77 per cent increase over the PCP.
CCO introduced Fiji Kava Noble Focus, its first Nootropic product, in the Australian market in July.
Meanwhile, the company established a global distribution partnership with Leilo and entered into a distribution partnership with Naturally Elevated in Australia.
Additionally, CCO collaborated with RooLife Group (ASX:RLG) to launch the Fiji Kava product range on Alibaba’s Tmall Global platform.
“We are now solely focused on growing across four sales growth pillars,” CCO CEO Anthony Noble said.
The company’s cash position at the quarter’s end was $390,000.
CCO last traded at 0.4 cents.
